Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy. | PSNet

Provide Feedback |

Register

Study

Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy.

March 24, 2021

Booth JP, Kennerly-Shah JM, Hartman AD. J Oncol Pharm Pract. 2022;28(2):381-386.

View more articles from the same authors.

The American Society of Clinical Oncology/Oncology Nursing Society and the Institute for Safe Medication Practices (ISMP) recommend independent double checks for certain medications In this retrospective study, pharmacists performed independent double checks on 1,645 anti-cancer parenteral orders. Pharmacists identified 30 errors during the first verification, and 10 errors on the second, resulting in a 33.3% increase in corrected errors.

PubMed citation

Related Resources From the Same Author(s)

Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapy.

July 29, 2020

Obtaining the best possible medication history at hospital admission: description of a pharmacy technician-driven program to identify medication discrepancies.

June 23, 2021

Use of therapeutic outcomes monitoring method for performing of pharmaceutical care in oncology patients.

April 28, 2021

Effect of illness severity and comorbidity on patient safety and adverse events.

January 4, 2012

Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy.

January 23, 2017

Improved medication management with introduction of a perioperative and prescribing pharmacist service.

August 12, 2020

Does root cause analysis improve patient safety? A systematic review at the Department of Veterans Affairs.

March 2, 2022

Developing a comprehensive framework of safeguarding strategies to address anticipated errors with organizational high-alert medications.

January 31, 2024

Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts.

February 17, 2021

Critical care simulation education program during the COVID-19 pandemic.

November 10, 2021

View More

Related Resources

The effect of documenting patient weight in kilograms on pediatric medication dosing errors in emergency medical services.

May 3, 2023

Accuracy of spinal anesthesia drug concentrations in mixtures prepared by anesthetists.

January 11, 2023

Safer prescribing and care for the elderly (SPACE): cluster randomised controlled trial in general practice.

December 15, 2021

Medication errors during treatment with new oral anticancer agents: consequences for clinical practice based on the AMBORA Study.

November 3, 2021

Use of therapeutic outcomes monitoring method for performing of pharmaceutical care in oncology patients.

April 28, 2021

The randomized AMBORA trial: impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents.

April 21, 2021

In the eye of the storm: the role of the pharmacist in medication safety during the COVID-19 pandemic at an urban teaching hospital.

December 23, 2020

Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapy.

July 29, 2020

Structural racism--a 60-year-old black woman with breast cancer.

April 10, 2019

Pharmacist medication reviews to improve safety monitoring in primary care patients.

July 18, 2016

View More

See More About The Topic

Ambulatory Clinic or Office

Facility and Group Administrators

Quality and Safety Professionals

Medical Oncology

Specific to High-Risk Drugs

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364